ESTIMATING THE COST-EFFECTIVENESS PROFILE OF A VACCINATION PROGRAMME WITH A NINE-VALENT HPV VACCINE IN ITALY

被引：3
|
作者：
Mennini, F. S. [1 ]
Bianic, F. [2 ]
Baio, G. [3 ]
Largeron, N. [4 ]
Plazzotta, G. [5 ]
Rinaldi, A. [6 ]
De Waure, C. [7 ]
Bonanni, P. [8 ]
机构：
[1] Univ Rome, Fac Econ, CEIS, Econ Evaluat & HTA EEHTA, Rome, Italy
[2] Mapi, Nanterre, France
[3] UCL, London, England
[4] SPMSD, Lyon, France
[5] Mapi, Uxbridge, Middx, England
[6] SPMSD, Rome, Italy
[7] Univ Cattolica Sacro Cuore, Rome, Italy
[8] Univ Firenze, Florence, Italy
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1171
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN154
引用
收藏
页码：A457 / A457
页数：1
相关论文
共 50 条
  • [1] ESTIMATING THE COST-EFFECTIVENESS PROFILE OF A UNIVERSAL VACCINATION PROGRAMME WITH A NINE-VALENT HPV VACCINE IN AUSTRIA
    Boiron, L.
    Joura, E.
    Largeron, N.
    Prager, B.
    Nikoglou, T.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A585 - A585
  • [2] Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria
    Boiron, L.
    Joura, E.
    Largeron, N.
    Prager, B.
    Uhart, M.
    [J]. BMC INFECTIOUS DISEASES, 2016, 16
  • [3] Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria
    L. Boiron
    E. Joura
    N. Largeron
    B. Prager
    M. Uhart
    [J]. BMC Infectious Diseases, 16
  • [4] Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
    Mennini, Francesco Saverio
    Bonanni, Paolo
    Bianic, Florence
    de Waure, Chiara
    Baio, Gianluca
    Plazzotta, Giacomo
    Uhart, Mathieu
    Rinaldi, Alessandro
    Largeron, Nathalie
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2017, 15
  • [5] Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
    Francesco Saverio Mennini
    Paolo Bonanni
    Florence Bianic
    Chiara de Waure
    Gianluca Baio
    Giacomo Plazzotta
    Mathieu Uhart
    Alessandro Rinaldi
    Nathalie Largeron
    [J]. Cost Effectiveness and Resource Allocation, 15
  • [6] COST-EFFECTIVENESS OF GENDER-NEUTRAL NINE-VALENT HPV VACCINATION IN DENMARK
    Olsen, J.
    le Fevre, T.
    Blaakaer, J.
    [J]. VALUE IN HEALTH, 2018, 21 : S229 - S229
  • [7] The cost-effectiveness of bivalent, quadrivalent, and nine-valent HPV vaccination in Asia: a systematic review
    Ke Zhu
    Yuke Tian
    Xiaomei Dong
    Babatunde O. Akinwunmi
    Casper J. P. Zhang
    Jian Huang
    Wai-kit Ming
    [J]. Archives of Gynecology and Obstetrics, 2022, 306 : 173 - 187
  • [8] The cost-effectiveness of bivalent, quadrivalent, and nine-valent HPV vaccination in Asia: a systematic review
    Zhu, Ke
    Tian, Yuke
    Dong, Xiaomei
    Akinwunmi, Babatunde O.
    Zhang, Casper J. P.
    Huang, Jian
    Ming, Wai-kit
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 306 (01) : 173 - 187
  • [9] Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France
    Majed, Laureen
    Bresse, Xavier
    El Mouaddin, Nadia
    Schmidt, Aurelie
    Daniels, Vincent J.
    Pavelyev, Andrew
    Levy-Bachelot, Laurie
    Elbasha, Elamin
    [J]. VACCINE, 2021, 39 (02) : 438 - 446
  • [10] Nine-valent HPV vaccine - new generation of HPV vaccine
    Fait, T.
    Dvorak, V
    Pilka, R.
    [J]. CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY, 2015, 80 (06): : 397 - 400
12345